CA2561293A1 - Treatment of incontinence - Google Patents
Treatment of incontinence Download PDFInfo
- Publication number
- CA2561293A1 CA2561293A1 CA002561293A CA2561293A CA2561293A1 CA 2561293 A1 CA2561293 A1 CA 2561293A1 CA 002561293 A CA002561293 A CA 002561293A CA 2561293 A CA2561293 A CA 2561293A CA 2561293 A1 CA2561293 A1 CA 2561293A1
- Authority
- CA
- Canada
- Prior art keywords
- incontinence
- treatment
- venlafaxine
- humans
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010021639 Incontinence Diseases 0.000 title 1
- 206010046543 Urinary incontinence Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- PNVNVHUZROJLTJ-UHFFFAOYSA-N venlafaxine Chemical compound C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 PNVNVHUZROJLTJ-UHFFFAOYSA-N 0.000 abstract 1
- 229960004688 venlafaxine Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Urinary incontinence in humans is treated by administration of venlafaxine, or a pharmaceutically acceptable acid addition salt thereof.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15812193A | 1993-11-24 | 1993-11-24 | |
| US08/158,121 | 1993-11-24 | ||
| CA002136120A CA2136120C (en) | 1993-11-24 | 1994-11-18 | Treatment of incontinence |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002136120A Division CA2136120C (en) | 1993-11-24 | 1994-11-18 | Treatment of incontinence |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2561293A1 true CA2561293A1 (en) | 1995-05-25 |
| CA2561293C CA2561293C (en) | 2008-03-18 |
Family
ID=37451524
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002561293A Expired - Lifetime CA2561293C (en) | 1993-11-24 | 1994-11-18 | Treatment of incontinence |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2561293C (en) |
-
1994
- 1994-11-18 CA CA002561293A patent/CA2561293C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2561293C (en) | 2008-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2259012A1 (en) | S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders | |
| NO2005004I1 (en) | Duloxetine and its pharmaceutically acceptable acid addition salts, especially duloxetine hydrochloride | |
| CA2160366A1 (en) | Risperidone pamoate | |
| CA2213339A1 (en) | Method of treating adenosine depletion | |
| EP0815860A3 (en) | Terfenadine carboxylate and the treatment of allergic disorders | |
| CA2263561A1 (en) | Thienopyrimidines | |
| CA2130805A1 (en) | Use of mannose phosphates for the treatment of fibrotic disorders | |
| EG20273A (en) | Process for preparing of pyrazolopyrimidines and their use in the treatment of stress related and other diseases | |
| RO116342B1 (en) | Oral liquid pharmaceutical composition | |
| EP1029540A3 (en) | Use of droloxifene for the treatment of cardiovascular diseases | |
| CA2180535A1 (en) | A method for treatment of psoriasis, by omeprazole or related compounds | |
| CA2154103A1 (en) | Treatment of Mucous Membrane Disease, Trauma or Condition and for the Relief of Pain | |
| CA2132416A1 (en) | Use of transglutaminase inhibitor for the treatment of scar tissue | |
| AU1117092A (en) | Treatment of lower urinary tract disorders | |
| CA2113916A1 (en) | 6-Chloro-5-Fluoro-3-(2-Thenoyl)-2-Oxindole-1-Carboxamide as an Analgesic and Anti-Inflammatory Agent | |
| WO1997005862A3 (en) | Use of basic amino acids and derivatives for lowering ceramide levels | |
| AU2713992A (en) | Therapeutic agent | |
| WO2001010427A3 (en) | Use of anti-muscarinic agents for treating skin disorders | |
| EP0342587A3 (en) | Thienotriazolodiazepine compounds and pharmaceutical uses thereof | |
| CA2120319A1 (en) | Pharmaceutical for the treatment of skin disorders | |
| CA2018791A1 (en) | Hair treatment composition | |
| NZ303993A (en) | Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders | |
| CA2561293A1 (en) | Treatment of incontinence | |
| EP1016408A4 (en) | C-c chemokine production inhibitor | |
| CA2179634A1 (en) | 4-arylisoindole analgesics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20141118 |